Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.51 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | SMO | Q99835 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31678976 | 0.86 | SIRT2 (0.57) | SIRT2TRPA1MAPTKDM4EALDH1A1 | |
| SCHEMBL3639133 | 0.86 | SIRT2 (0.57) | SIRT2TRPA1MAPTKDM4EALDH1A1 | |
| SCHEMBL2037764 | 0.86 | SIRT2 (0.57) | SIRT2TRPA1MAPTKDM4EALDH1A1 | |
| SCHEMBL7928539 | 0.83 | TRPA1 (0.59) | SIRT2TRPA1MAPTNFE2L2CYP2C19 | |
| SCHEMBL28053289 | 0.82 | SIRT2 (0.50) | SIRT2TRPA1MAPTKDM4EALDH1A1 | |
| SCHEMBL114584 | 0.79 | PTPN1 (0.49) | TRPA1MAPTALDH1A1LMNANFE2L2 | |
| Hydrochloric Acid SCHEMBL894924 | 0.78 | PTPN1 (0.47) | TRPA1MAPTALDH1A1LMNANFE2L2 | |
| Hydrochloric Acid SCHEMBL9622267 | 0.78 | PTPN1 (0.47) | TRPA1MAPTALDH1A1LMNANFE2L2 | |
| SCHEMBL9464203 | 0.77 | TRPA1 (0.46) | SIRT2TRPA1ALDH1A1HPGDNFE2L2 | |
| SCHEMBL7751066 | 0.77 | TRPA1 (0.46) | TRPA1MAPTALDH1A1LMNANFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118707642-A | High-color-gamut backlight module and preparation method thereof | 湖南壹鑫科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118707642-A | High-color-gamut backlight module and preparation method thereof | 湖南壹鑫科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| EP-1818417-B1 | Nanoparticles having oligonucleotides attached thereto and uses therefor | NANOSPHERE INC (US) | 2014-02-12 | — | — | EP | disclosed |
| US-8323888-B2 | Nanoparticles having oligonucleotides attached thereto and uses therefor | NANOSPHERE, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| EP-1294930-B1 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | NANOSPHERE INC (US) | 2011-03-30 | — | — | EP | disclosed |
| EP-1198591-B1 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | NANOSPHERE INC (US) | 2011-03-16 | — | — | EP | disclosed |
| EP-1301625-B1 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | NANOSPHERE INC (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2001051665-A9 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | NANOSPHERE INC. (US) | 2010-09-23 | — | — | WO | disclosed |
| US-20090325812-A1 | Nanoparticles having oligonucleotides attached thereto and uses therefor | NANOSPHERE, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| EP-1198591-A4 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | NANOSPHERE INC (US) | 2007-10-24 | — | — | EP | disclosed |
| US-6010907-A | TRANSFORMING TARGET DNA SEQUENCES | KIMERAGEN, INC. (US) | 2000-01-04 | — | — | US | disclosed |
| US-6004804-A | 3'-EXONUCLEASE PROTECTED DUPLEX MUTATIONAL VECTORS; USED TO MAKE SPECIFIC GENETIC ALTERATIONS IN THE GENOME AND IN PLASMIDS OF TARGET PROKARYOTIC CELLS | KIMERAGEN, INC. (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1999058723-A1 | HETERODUPLEX MUTATIONAL VECTORS AND USE THEREOF IN BACTERIA | KIMERAGEN, INC. (US) | 1999-11-18 | — | — | WO | disclosed |
| WO-1999058702-A1 | CELL-FREE CHIMERAPLASTY AND EUKARYOTIC USE OF HETERODUPLEX MUTATIONAL VECTORS | KIMERAGEN, INC. (US) | 1999-11-18 | — | — | WO | disclosed |
| WO-1999040789-A1 | METHODS AND COMPOUNDS FOR THE GENETIC TREATMENT OF HYPERLIPIDEMIA | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1999-08-19 | — | — | WO | disclosed |
| EP-0918885-A1 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | Nanosphere LLC (US) | 1999-06-02 | — | — | EP | disclosed |
| US-5780613-A | DISPLACING 5' DISPLACEABLE GROUP BY A 3' THIOPHOSPHORYL GROUP TO FORM INTERNUCLEOSIDE LINKAGE | NORTHWESTERN UNIVERSITY (US) | 1998-07-14 | — | — | US | disclosed |
| WO-1998004740-A9 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | — | 1998-04-30 | — | — | WO | disclosed |
| WO-1998004740-A1 | NANOPARTICLES HAVING OLIGONUCLEOTIDES ATTACHED THERETO AND USES THEREFOR | NANOSPHERE LLC (US) | 1998-02-05 | — | — | WO | disclosed |
| WO-1997005284-A1 | COVALENT LOCK FOR SELF-ASSEMBLED OLIGONUCLEOTIDE CONSTRUCTS | NORTHWESTERN UNIVERSITY (US) | 1997-02-13 | — | — | WO | disclosed |